1/89
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Arboviruses (arthropod-borne viruses)
transmitted primarily by arthropod vectors, such as mosquitoes, flies, ticks and fleas
over 500
How many arboviruses are recognized worldwide?
150
How many arboviruses are known to cause disease in humans?
over 3,000
How many mosquito species are there?
Anopheles, Aedes and Culex
The most dangerous mosquitoes are certain species of
Culex Mosquitoes
Typically bite at night both indoors and outdoors; they prefer avian hosts, but will bite humans (West Nile Virus, Western Equine encephalitis, Eastern Equine encephalitis)
Anopheles Mosquitoes
Bite indoors and outdoors between dusk and dawn and prefer human and mammal hosts. (Malaria)
Aedes Mosquitoes
Unlike the “typical” mosquito of the U.S., they are active day biters and humans are their preferred hosts (Zika, Chikungunya, Yellow Fever, Dengue)
female
only ______ mosquitos bite
produce eggs
Most female mosquitoes must blood-feed on a vertebrate host to
injects saliva into the host, which serves as an anticoagulant (also induces inflammatory response)
While taking a blood meal, the female
The virus circulates and multiplies in the mosquito's hemolymph (blood) for several days. The virus then penetrates and infects the mosquito's salivary glands. After an incubation period of 1-2 weeks, the infected mosquito can transmit viruses to humans and animals while taking blood meals.
How do mosquitos act as vectors?
disease
Arthopods have no apparent
for life
in the arthropod vector diseases persist
ovarilly
virus can be transmitted _____________ to vector progeny (over winter)
birds, rodents, reptiles
Who are the reservoir hosts for arboviruses?
horses, humans
What mammals are dead-end hosts for arboviruses?
Chikunguya, Dengue, Yellow Fever, and Zika
Humans can be the primary vertebrae host for
Russia, Spain, South Africa
Since the 50s several “large” outbreaks of West Nile virus occurred sporadically, including epidemics in
birds → mosquito
mosquito → birds
birds → mosquito → human
birds → mosquito → horse
West Nile virus Transmission Cycle
birds
West Nile virus Reservoir
more sick
Horses often get _________ than people when infected with WNV
better
WN02 can replicate in mosquitos
lymph nodes → spleen → brain
WNV pathogenesis
Fatigue, swollen lymph nodes
WNV pathogenesis (lymph nodes)
Replicates in brain, inflammation of the brain
WNV pathogenesis (brain)
75%
how many people with WNV are asymptomatic?
25%
How many people with WNV develop West Nile fever?
1%
How many people with WNV get it in their brain?
50%
How many people who have WNV in their brain die?
Unpredictable outbreaks, Economic considerations, Lack of progression to phase 3 trials, Regulatory challenges
Why is there no vaccine for humans?
Surveillance & mosquito control, elimination of standing waters (Plant pots, gutters), Finding and monitoring places where adult mosquitos lay eggs, Tracking mosquito populations and the viruses they may be carrying
Reducing West Nile risk
their hosts
Some herpesviruses (HSV1) have coevolved with
switch
Some herpesviruses (HSV2) _____ hosts
Relatively “large” virus, Genome is made of DNA, Encode 70 to 200+ proteins
Herpes virus
They are successful pathogens extremely well adapted to their hosts, No - or little - clinical symptoms, High infection rates within their host population, infection is lifelong
Some generalities about herpesviruses
latency and the lytic cycles
To persist in their host, Herpesviruses have adopted two different modes of life cycle
Dormant (very little expression - no virions produced)
latency phase
Reactivation (Virions are made - Cell death)
lytic cycle
Upon infection the viral DNA is transported to the nucleus
where it circularizes, The circular form is called an
episome, The episome is maintained in the nucleus of the infected cell, No (or very little) viral expression
How does latency hides infection?
Maintenance of the viral reservoir in the host, Viral spread to new hosts, Reactivation is not associated with
disease but under certain circumstances it may be accompanied by clinical symptoms
What happens during the Reactivation stage
well understood
stimuli relating to reactivation are not
innate and active
Herpesviruses excel at evading immune responses
immune evasion
A large fraction of herpesvirus genomes are dedicated to
The apha herpesviruses
Herpes simplex virus 1 (HSV1)
Herpes simplex virus 2 (HSV2)
Varicella Zoster virus VZV)
The beta herpesviruses
Cytomegalovirus (CMV)
Human Herpesvirus 6 (HHV6)
Human Herpesvirus 7 (HHV7
The gamma herpesviruses
Epstein-Barr Virus (EBV)
Kaposi’s sacoma associated herpesvirus (KSHV)
cold sores
HSV1
Genital herpes
HSV2
chicken pox, shingles
VZV
Retinitis, birth defect
CMV
Roseola
HHV6, HHV7
mono, lymphoma, carcinoma
EBV
Sarcoma
KSHV
Filoviridae family, RNA virus but unusual structure and genetic
sequence, virions
Ebola Virus
1000nm
Virions are variable in length but on average are
manifests 2-21 days after exposure (onset of 8-10 days), symptoms progress over time
Ebola virus disease
fruit bats, dead carcasses of antelopes + gorillas
Though Ebola virus is “found” in
Democratic Republic of Congo in 1976
The first outbreak of Ebola virus disease was reported in
318 cases and 218 deaths
the 1978 ebola outbreak in the DRC resulted in
dry to wet
ebola symptoms generally progress from
headache, fever, sore throat, aching muscles, extreme weakness
dry symptoms
nose bleeds, impaired liver function, rash, vomiting, impaired kidney function, diarrhea, internal & external bleeding, multiple organ failure
wet symptoms
macrophages in the liver (fluid loss leads to liver dysfunction)
ebola infects
Viral cytotoxicity, Cytokine storm, Excessive coagulation, Immune collapse, Shock and multi-organ failure
How does Ebola cause mortality?
Viral cytotoxicity
organ damage (especially liver)
Cytokine storm
systemic inflammation and vascular leakage
Excessive coagulation
hemorrhage and microthrombi
Immune collapse
uncontrolled viral spread
ear, testis, eye, brain, uterus, muscle joint
ebola virus clearance might be delayed in
blood, organs or other bodily fluids of infected persons, Contaminated Objects, Infected animals
The Ebola virus is transmitted by direct contact with
symptomatic
Transmission of ebola occurs once someone is
close family contacts, burial ceremonies, in hospitals
Human to human transmission occurred via
nosocomial infections
Hospital acquired infections are referred to as
40
From 1976 to 2022, over __ outbreaks of ebola have occurred
16
How many ebola outbreaks were in the DRC?
25% to 90%
Case fatality for ebola ranges from
zaire
Outbreaks are typically ebola
1,850 identified cases with over 1,200 deaths
1976 - Jan 2014 stats for ebola
28,616 identified cases with 11,310 deaths, This epidemic had 40% mortality but more spread of infection, 6 months for aid organizations to get involved
2014-15 ebola outbreak
a lot of outbreaks in many countries, took aid organizations a long time to get involved, nonspecific treatment, big structures for patients and their families had to be built, aid orgs were inexperienced with ebola, authoritarian tactics scared people
Challenges associated with the 2014-2015 epidemic
re-infection
those who "survive" ebola infection are thought to be protected from
antibody responses (IgG)
There are significant _______________________ to the Ebola virus in people who recover from infection
people with active infection
Passive transfer of IgG antibodies from people who recovered
from Ebola was shown to be beneficial to
Vesicular stomatitis virus (VSV)
causes blister-like lesions in livestock
DNA inserted into VSV utbo
First vaccine for ebola VSV
contact tracing done to follow people for 21 days and vaccinate everyone exposed
ebola outbreak monitoring
they appear
Symptoms of Ebola virus disease (EVD) are treated as
Antiviral Drugs (ebola)
Monoclonal antibodies, stops replication of ebola
vaccine, rapid diagnostic tests, treatment centers, monoclonal antibody therapies, public education, contact tracing, coordination with affected countries, quarantine, surveillance
new and improved strategy for handling ebola